{"id":"W4405096057","doi":"10.1182/blood-2024-202516","title":"CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Lymphoma; Randomized controlled trial; Internal medicine; Oncology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002256494,0.001668363,0.002317451,0.0004419812,0.0005103435,0.001372136,0.001064443,0.001450913,0.008404755],"category_scores_gemma":[0.001749876,0.000693394,0.001324836,0.0003919755,0.001183934,0.001136711,0.000533511,0.003205482,0.001349488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009792555,"about_ca_system_score_gemma":0.001536752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008478267,"about_ca_topic_score_gemma":0.002404113,"domain_scores_codex":[0.9992365,0.0004385429,0.00004528961,0.0001153075,0.00004967753,0.0001148098],"domain_scores_gemma":[0.9989053,0.0002000351,0.0002585823,0.00007489392,0.00006721,0.0004940091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9794407,0.007566163,0.0008171927,0.000348626,0.0004900562,0.000038232,0.00003361065,0.0002475834,0.002064209,0.0001038377,0.001143311,0.00770648],"study_design_scores_gemma":[0.9520002,0.04562789,0.0011541,0.00002104728,0.0001681549,0.00002818753,0.00001244127,0.0001879618,0.0001361313,0.00007098439,0.0005868045,0.000005963509],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9724897,0.003693369,0.0007771029,0.001650685,0.0009440234,0.0139012,0.002298678,0.0001897232,0.004055531],"genre_scores_gemma":[0.9638641,0.002340975,0.002354137,0.00258635,0.0006983846,0.019931,0.003266086,0.00003149155,0.004927492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008404755,"threshold_uncertainty_score":0.0281167,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01035496836627088,"score_gpt":0.2641386881902382,"score_spread":0.2537837198239673,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}